Top compounds associated with response to TSTD3


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 5e-05
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 0.0001
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA bendamustine CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA BRD-K61166597 CTRPv2 pan-cancer AAC -0.11 0.0004
mRNA niclosamide CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.12 0.0006
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.13 0.0009
Download CSV